X4 Pharmaceuticals (XFOR) Shares Repurchased (2023)
X4 Pharmaceuticals posted quarterly Shares Repurchased of $443000.0 for Q1 2023.
X4 Pharmaceuticals (XFOR) has 1 years of Shares Repurchased data on file, last reported at $443000.0 in Q1 2023.
- For the quarter ending Q1 2023, Shares Repurchased changed N/A year-over-year to $443000.0; the trailing twelve-month figure through Mar 2023 stood at $443000.0 (changed N/A YoY), and the FY2021 full-year result was $2.0 million, changed N/A from the prior year.
- Shares Repurchased for Q1 2023 stood at $443000.0.
- Across five years, Shares Repurchased topped out at $443000.0 in Q1 2023 and bottomed at $443000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 443,000.00 |
| Mar 31, 2023 | 443,000.00 |